SOPHARMA AD: Transaction within the scope of art. 114, para. 2 of the Law on Public offering of secirities

2024-12-19 13:57

Spis treści:

reklama

Spis załączników:
SFA 19122024 Phramalogistica 114 espi.pdf (REPORT)

przewiń, aby zobaczyć całą tabelę

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		145	/	2024
Date of issue:	2024-12-19
Short name of the issuer
SOPHARMA AD
Subject
Transaction within the scope of art. 114, para. 2 of the Law on Public offering of secirities
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, December 19, 2024 - Pursuant to the requirements of Article 100t of the LPOS and in conjunction with Article 114, par. 9 of the LPOS, "Sopharma" AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) hereby informs, that The Board of Directors, at its meeting held on December 19, 2024, in accordance with the requirements of art. 114, para 2 of the LPOS and in accordance with the Group's strategy for optimization and focus on health related activities, approved the conclusion of the following transaction:
Annexes
File			Description
SFA 19122024 Phramalogistica 114 espi.pdfSFA_19122024_Phramalogistica_114_espi.pdf			Transaction within the scope of art. 114, para. 2 of the Law on Public offering of secirities

przewiń, aby zobaczyć całą tabelę

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

przewiń, aby zobaczyć całą tabelę

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2024-12-19	Ognian Donev	Execurive director

Źródło: Komunikaty spółek (ESPI)

0

Rynki